Brevan Howard Capital Management LP
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1512857
ST. HELIER, Y9
Position in BIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,027,741
+$2,947,585 QoQ
Shares Held
13,718
+254.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#106
of 392 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $43,706,598 across 34 Medical Devices names. BIO ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
20,654 | $4,349,112 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
13,718 | $4,027,741 | |
| 3 | UFPT |
Ufp Technologies Inc
|
13,400 | $3,552,742 | |
| 4 | EW |
Edwards Lifesciences Corp
|
34,889 | $3,156,058 | |
| 5 | BSX |
Boston Scientific Corp
|
68,883 | $2,939,925 | |
| 6 | SYK |
Stryker Corp
|
9,013 | $2,837,652 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
23,847 | $2,836,600 | |
| 8 | DXCM |
Dexcom Inc
|
32,813 | $2,209,955 |
All Filings in BIO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,027,741 | 13,718 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,080,156 | 3,875 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $1,567,940 | 5,592 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,264,154 | 21,814 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $3,708,150 | 11,083 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $616,682 | 2,258 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $295,718 | 855 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $454,306 | 1,407 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||